152 related articles for article (PubMed ID: 3844975)
21. Proliferation of mature and immature subpopulations of bronchoalveolar monocytes/macrophages and peripheral blood monocytes.
van Hal PT; Wijkhuijs JM; Mulder PG; Hoogsteden HC
Cell Prolif; 1995 Oct; 28(10):533-43. PubMed ID: 7488673
[TBL] [Abstract][Full Text] [Related]
22. Human lung macrophages enhance and inhibit lymphocyte proliferation.
Liu MC; Proud D; Schleimer RP; Plaut M
J Immunol; 1984 Jun; 132(6):2895-903. PubMed ID: 6609963
[TBL] [Abstract][Full Text] [Related]
23. Tumor killing by human alveolar macrophages and blood monocytes. Decreased cytotoxicity of human alveolar macrophages.
Weissler JC; Lipscomb MF; Lem VM; Toews GB
Am Rev Respir Dis; 1986 Sep; 134(3):532-7. PubMed ID: 3019195
[TBL] [Abstract][Full Text] [Related]
24. Peripheral blood monocytes derived from HIV+ individuals mediate antibody-dependent cellular cytotoxicity (ADCC).
Jewett A; Bonavida B
Clin Immunol Immunopathol; 1990 Feb; 54(2):192-9. PubMed ID: 2104787
[TBL] [Abstract][Full Text] [Related]
25. Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.
Chang ZL; Whiteside TL; Herberman RB
Cell Immunol; 1990 Jan; 125(1):183-96. PubMed ID: 2293898
[TBL] [Abstract][Full Text] [Related]
26. Phenotype of blood monocytes and alveolar macrophages in interstitial lung disease.
Hoogsteden HC; van Dongen JJ; van Hal PT; Delahaye M; Hop W; Hilvering C
Chest; 1989 Mar; 95(3):574-7. PubMed ID: 2920586
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic activity of human pulmonary alveolar macrophages.
Kan-Mitchell J; Hengst JC; Kempf RA; Rothbart RK; Simons SM; Brooker AS; Kortes VL; Mitchell MS
Cancer Res; 1985 Jan; 45(1):453-8. PubMed ID: 3965151
[TBL] [Abstract][Full Text] [Related]
28. In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.
Hammerstrøm J
Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):391-9. PubMed ID: 397718
[TBL] [Abstract][Full Text] [Related]
29. Different patterns of arachidonate metabolism in autologous human blood monocytes and alveolar macrophages.
Balter MS; Toews GB; Peters-Golden M
J Immunol; 1989 Jan; 142(2):602-8. PubMed ID: 2536058
[TBL] [Abstract][Full Text] [Related]
30. Decreased monocyte-mediated cytostasis of human cancer cell in patients with lung cancer.
Nakata Y; Yamashita J; Kishi T; Kataoka M; Ejiri T; Ohnoshi T; Kimura I
Cancer Immunol Immunother; 1985; 20(1):43-6. PubMed ID: 3851693
[TBL] [Abstract][Full Text] [Related]
31. Soluble cytostatic factor(s) released from human monocytes. I. Production and effect on normal and transformed human target cells.
Hammestrøm J
Scand J Immunol; 1982 Mar; 15(3):311-8. PubMed ID: 7089490
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of macrophages in lung cancer patients with special reference to location of macrophages.
Nakahashi H; Yasumoto K; Nagashima A; Yaita H; Takeo S; Motohiro A; Furukawa T; Inokuchi K; Nomoto K
Cancer Res; 1984 Dec; 44(12 Pt 1):5906-9. PubMed ID: 6498848
[TBL] [Abstract][Full Text] [Related]
33. Chemiluminescence and antibody-dependent, cell-mediated cytotoxicity between human alveolar macrophages and peripheral blood monocytes in smokers, nonsmokers, and lung cancer patients.
Lin CC; Huang WC; Lin CY
Chest; 1989 Mar; 95(3):553-7. PubMed ID: 2920582
[TBL] [Abstract][Full Text] [Related]
34. Two distinct cytolytic mechanisms of macrophages and monocytes activated by phorbol myristate acetate.
Chung T; Kim YB
J Leukoc Biol; 1988 Nov; 44(5):329-36. PubMed ID: 3183511
[TBL] [Abstract][Full Text] [Related]
35. Inflammation and anti-tumor resistance. V. Production of a cytostatic factor following cooperation of elicited polymorphonuclear leukocytes and macrophages.
Hevin MB; Friguet B; Fauve RM
Int J Cancer; 1990 Sep; 46(3):533-8. PubMed ID: 2203691
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity to tumour cells induced in human monocytes cultured in vitro in the presence of different sera.
Unsgaard G
Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):141-9. PubMed ID: 443049
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
38. Interactions between human macrophages and tumor cells in three-dimensional cultures.
Audran R; Dazord L; Toujas L
Cancer Immunol Immunother; 1994 Nov; 39(5):299-304. PubMed ID: 7987861
[TBL] [Abstract][Full Text] [Related]
39. Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease.
Millar AB; Miller RF; Foley NM; Meager A; Semple SJ; Rook GA
Am J Respir Cell Mol Biol; 1991 Aug; 5(2):144-8. PubMed ID: 1892644
[TBL] [Abstract][Full Text] [Related]
40. Modulation of pokeweed-mitogen-induced immunoglobulin secretion by human bronchoalveolar cells.
Lawrence EC; Theodore BJ; Martin RR
Am Rev Respir Dis; 1982 Aug; 126(2):248-52. PubMed ID: 6213186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
